Bacteriostatic Water — What It Is and How It's Used

Bacteriostatic water is the liquid most commonly used for reconstituting lyophilized research peptides. It is a specific product — not the same as tap water, distilled water, or plain sterile water for injection. This guide explains what it is, what it contains, how it differs from sterile water for injection, how published literature and manufacturer documentation describe its shelf life, and why it is the preferred diluent for multi-use peptide reconstitution protocols.

Nothing here is medical advice. This article is an educational reference for users who have already decided to work with a particular compound in consultation with a licensed healthcare provider.

What bacteriostatic water is

Bacteriostatic water for injection (USP) is a sterile, non-pyrogenic preparation of water containing a preservative. The most common formulation is 0.9% benzyl alcohol as the bacteriostatic agent. The word “bacteriostatic” means that the preservative inhibits bacterial growth — it does not actively kill bacteria, but it stops them from multiplying in the vial once the seal has been punctured. This is distinct from “bactericidal,” which would actively kill microorganisms.

Pharmaceutical bacteriostatic water is typically supplied in 10 mL, 20 mL, or 30 mL multi-use glass or plastic vials with a rubber stopper and metal crimp. It is a prescription product in the United States, though regulations on practical access vary. It is widely used in clinical settings for diluting injectable drugs that come as freeze-dried powders.

The USP monograph specifies the minimum purity, the preservative, and the packaging standards. Labels typically note that the product is intended for multiple-use parenteral preparations and state the packaging volume and expiration.

Why a preservative matters for peptide reconstitution

Lyophilized research peptides are typically reconstituted in quantities that are consumed over days or weeks. Every time a needle is inserted through the rubber stopper of a reconstituted peptide vial, there is a small opportunity for microorganisms to enter. If the diluent had no preservative — for example, plain sterile water for injection — the reconstituted peptide vial would become a growth medium the moment bacteria entered, and would have a practical shelf life measured in hours rather than weeks.

The benzyl alcohol preservative in bacteriostatic water suppresses bacterial growth in the reconstituted vial, extending the usable window considerably. This is the core reason bacteriostatic water is the default diluent for multi-use peptide reconstitution protocols.

Published manufacturer documentation for bacteriostatic water typically indicates that the preservative’s effectiveness after the vial has been entered is rated for approximately 28 days under refrigeration. This is the origin of the commonly repeated “28-day” rule for reconstituted vials — the constraint is not the peptide itself (which may be stable longer under refrigeration) but the preservative’s guaranteed lifetime after the bacteriostatic water container has been punctured.

Bacteriostatic water vs. sterile water for injection

These are not the same product, even though both are sterile aqueous solutions. The distinction matters:

Sterile water for injection is sometimes preferred in contexts where the preservative is contraindicated — for example, published pediatric and neonatal guidance generally avoids benzyl alcohol because of historical concerns about tolerability in very small infants (the “gasping baby syndrome” reports from the 1980s). These constraints are not usually relevant to adult research peptide reconstitution but are worth knowing about.

There is also plain distilled water (not sterile, not preserved, not pyrogen-free) and tap water, neither of which should be used for injection — not for dilution of research peptides, not for anything. This should be obvious, but it is stated explicitly here because the question does come up.

What the volume of water actually does

A reasonable question: if the peptide is going to be the same mass regardless, why does it matter how much bacteriostatic water you add?

It matters because the volume of water determines the concentration, which determines the draw volume for a given dose, which determines how easy it is to read accurately on a syringe.

Consider a 5 mg peptide vial and a 250 mcg target dose. Here’s what happens with different amounts of bacteriostatic water:

• 1 mL of water: concentration = 5 mg/mL = 5,000 mcg/mL. A 250 mcg dose = 250 ÷ 5,000 = 0.05 mL = 5 units on a U-100. Hard to read precisely — a 1-unit misread is a 20% error on dose.
• 2 mL of water: concentration = 2,500 mcg/mL. A 250 mcg dose = 250 ÷ 2,500 = 0.1 mL = 10 units. Easier to read — a 1-unit misread is a 10% error on dose.
• 5 mL of water: concentration = 1,000 mcg/mL. A 250 mcg dose = 250 ÷ 1,000 = 0.25 mL = 25 units. Very easy to read, but the draw is getting close to the capacity of a 0.3 mL barrel.

The tradeoff is straightforward. More water = more dilute = bigger draw = easier to read but closer to capacity limits. Less water = more concentrated = smaller draw = uses less water but harder to measure precisely. Most published user reports describe choosing a dilution that puts the typical per-injection draw somewhere between 5 and 30 units on a U-100 0.3 mL or 0.5 mL syringe — large enough to measure comfortably, small enough to fit in a low-capacity barrel.

The calculator on the homepage lets you experiment with different water volumes and instantly see what the draw would be, so you can pick a dilution that lands in a comfortable range before committing.

Storage and handling of bacteriostatic water

Published manufacturer documentation for bacteriostatic water for injection typically describes the following handling practices:

• Before opening: store at controlled room temperature, usually with a note not to exceed a specified temperature (often around 25°C / 77°F). Check the specific product label for exact conditions.
• After opening (puncturing): manufacturer rating for preservative effectiveness is typically up to ~28 days under refrigeration at 2–8°C. Some labels allow for room-temperature storage for a shorter window.
• Light protection: typically not a major concern for bacteriostatic water itself, but the peptide vials reconstituted with it may have light-protection requirements of their own.
• Expiration before opening: check the printed date on the vial. Unused vials have a multi-year shelf life.
• Do not reuse a capped needle on a bac water vial across multiple peptide vials without swabbing: this introduces cross-contamination risk.

Sourcing

In the United States, bacteriostatic water is technically a prescription product, but practical availability varies widely. Compounding pharmacies, veterinary suppliers, and research chemical suppliers commonly list it alongside peptide products. Published user reports consistently emphasize buying from reputable suppliers; the quality of the diluent matters for the same reason the quality of the peptide matters.

This site does not make vendor recommendations and does not sell bacteriostatic water or any other product. That is by design. Sourcing decisions are entirely the user’s responsibility and should be informed by regulatory, legal, and quality considerations specific to the user’s jurisdiction.

Alternatives to bacteriostatic water

There are only a few alternatives in the research-peptide context, and each has tradeoffs:

• Sterile water for injection (no preservative): works for single-use protocols. Not appropriate for multi-use vials unless the reconstituted peptide is consumed within hours. No benzyl alcohol, which some users report preferring.
• Normal saline (0.9% sodium chloride): a sterile isotonic solution. Some published peptide protocols call for saline specifically because of buffer/osmolality considerations. Not inherently bacteriostatic.
• Specific buffer solutions: some peptides have published reconstitution protocols specifying acidic or basic buffers for stability. If your peptide has such a protocol, follow it rather than defaulting to bacteriostatic water.

For the typical research peptide reconstitution scenario, plain bacteriostatic water is the default. Published protocols that deviate from this default usually say so explicitly.

Common mistakes

• Confusing bacteriostatic water with sterile water for injection. They are different products with different shelf lives after opening.
• Reusing a bac water vial for 60+ days. The preservative is manufacturer-rated for ~28 days after puncture; beyond that, sterility is no longer assured.
• Using tap water, distilled water, or drinking water. None of these are sterile or pyrogen-free. This is not a joke — do not do it.
• Adding an odd volume because it was mentioned in a forum post. There is no magic number. The right volume is the one that puts your draw in a comfortable range on the syringe you are using. The calculator helps you see this visually.

Further reading on this site

• How to reconstitute peptides — the step-by-step physical process that uses bacteriostatic water.
• Peptide storage and shelf life — what published literature says about lyophilized and reconstituted stability.
• Reconstitution math from first principles — the arithmetic in slow motion.

Wrapping up

Bacteriostatic water is the standard diluent for multi-use peptide reconstitution because its benzyl alcohol preservative inhibits bacterial growth in the vial once the seal has been punctured. The volume of water you add doesn’t change the peptide mass but does change the concentration, which in turn shapes how easy it is to read the draw accurately on your chosen syringe. Manufacturer documentation typically rates preservative effectiveness at ~28 days under refrigeration after opening — that’s the practical shelf-life constraint, not the peptide itself. Use the calculator to experiment with different dilutions before committing to a specific water volume.